from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2656c/-

LFCtreatmentdescriptionclass of inhibitor

-0.316

Amikacinug/mL Amikacintranslation

-0.161

Cap5-10ug/mL Capreomycintranslation

0.135

Rox10-50 ug/mL Roxithromycintranslation

-0.293

SM2-5 ug/mL Streptomycintranslation

0.588

Tet5-10 ug/mL Tetracyclinetranslation

0.166

Rif0.2-5ug/mL Rifampicintranscription

-0.477

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.687

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.057

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.149

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.031

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.441

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.576

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.022

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.061

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.409

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.548

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.093

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.410

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.627

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.924

KCN5-20 ug/mL Potassium cyaniderespiration

-0.343

NaN30.2-2 mM Sodium aziderespiration

0.200

Nigericin50 uM Nigericinrespiration

-0.382

TRC10-150 ug/mL Triclosanrespiration

0.394

TRZ10-25 ug/mL Thioridazinerespiration

3.580

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.149

menadione6-10 ug/mL Menadionerespiration

-0.010

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.282

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.244

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.477

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.324

NRP_1Non-replicating persistence stage 1dosRassociated

-0.529

Amp0.2mg/mL AmpicillincellWall

-0.201

Cephalexin20-100 ug/mL CephalexincellWall

0.128

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.440

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.229

EMB10-20 ug/mL EthambutolcellWall

-0.305

Eta12-40 ug/mL EthionamidecellWall

-0.252

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.141

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.305

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.323

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.217

BZA0.12 mg/mL BenzamidearomaticAmides

0.034

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.003

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.233

H2O24 mM hydrogen peroxideDNAdamaging

-0.154

Levo10 ug/mL LevofloxacinDNAdamaging

-0.491

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.008

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.029

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.529

UVUV-irradiationDNAdamaging

0.991

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.525

Antimycin12.5-50 ug/mL Antimycin A?

-0.063

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.367

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.765

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.486

PA8240.2-2 ug/mL PA-824?

0.319

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.217

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.408

Verapamil50 uM Verapamil?

0.025

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.079

methoxatin10-20 ug/mL Methoxatin?